Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space – Part I: Adults (English)
- New search for: Pepin, Xavier J. H.
- New search for: Hammarberg, Maria
- Further information on Hammarberg, Maria:
- https://orcid.org/0000-0001-5796-9021
- New search for: Mattinson, Alexandra
- New search for: Moir, Andrea
- New search for: Pepin, Xavier J. H.
- New search for: Hammarberg, Maria
- Further information on Hammarberg, Maria:
- https://orcid.org/0000-0001-5796-9021
- New search for: Mattinson, Alexandra
- New search for: Moir, Andrea
In:
Pharmaceutical Research
;
40
, 2
; 387-403
;
2022
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space – Part I: Adults
-
Contributors:Pepin, Xavier J. H. ( author ) / Hammarberg, Maria ( author ) / Mattinson, Alexandra ( author ) / Moir, Andrea ( author )
-
Published in:Pharmaceutical Research ; 40, 2 ; 387-403
-
Publisher:
- New search for: Springer US
- New search for: Springer Science + Business Media B.V
-
Place of publication:Dordrecht [u.a.]
-
Publication date:2022
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
- New search for: 44.38$jPharmakologie / 44.38
- Further information on Basic classification
-
Keywords:
-
Classification:
BKL: 44.38$jPharmakologie / 44.38 Pharmakologie -
Source:
Table of contents – Volume 40, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 321
-
Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product DevelopmentWu, Di / Li, Min et al. | 2022
- 337
-
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic DrugsWu, Di / Sanghavi, Maitri / Kollipara, Sivacharan / Ahmed, Tausif / Saini, Anuj K / Heimbach, Tycho et al. | 2022
- 359
-
Prediction of Oral Drug Absorption in Rats from In Vitro DataAkiyama, Yoshiyuki / Matsumura, Naoya / Ono, Asami / Hayashi, Shun / Funaki, Satoko / Tamura, Naomi / Kimoto, Takahiro / Jiko, Maiko / Haruna, Yuka / Sarashina, Akiko et al. | 2022
- 375
-
Physiologically Based Absorption Modelling to Explore the Formulation and Gastric pH Changes on the Pharmacokinetics of AcalabrutinibZhou, Diansong / Chen, Buyun / Sharma, Shringi / Tang, Weifeng / Pepin, Xavier et al. | 2022
- 387
-
Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space – Part I: AdultsPepin, Xavier J. H. / Hammarberg, Maria / Mattinson, Alexandra / Moir, Andrea et al. | 2022
- 405
-
Integrating Forward and Reverse Translation in PBPK Modeling to Predict Food Effect on Oral Absorption of Weakly Basic DrugsFranco, Yesenia L. / Da Silva, Lais / Charbe, Nitin / Kinvig, Hannah / Kim, Soyoung / Cristofoletti, Rodrigo et al. | 2023
- 419
-
Physiologically based Pharmacokinetic Models under the Prism of the Finite Absorption Time ConceptWu, Di / Tsekouras, Athanasios A. / Macheras, Panos / Kesisoglou, Filippos et al. | 2022
- 431
-
Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and SimulationLe Merdy, Maxime / AlQaraghuli, Farah / Tan, Ming-Liang / Walenga, Ross / Babiskin, Andrew / Zhao, Liang / Lukacova, Viera et al. | 2022
- 449
-
In Silico Dosimetry Study of Tc99m-Tetrofosmin in Children Using a Novel PBPK Model in Humans Built from SPECT Imaging DataKaikousidis, Christos / Dokoumetzidis, Aristides et al. | 2022
- 459
-
What Do We Know About the Smallpox Virus? A Journey Between Clinic and TherapyZovi, Andrea / Ferrara, Francesco / Sorrentino, Sarah / Langella, Roberto / Trama, Ugo / Boccellino, Mariarosaria / Vitiello, Antonio et al. | 2022
- 467
-
Remodeling of Adipose Tissues by Fatty Acids: Mechanistic Update on Browning and Thermogenesis by n-3 Polyunsaturated Fatty AcidsRaj, Radha Raman / Lofquist, Sydney / Lee, Mi-Jeong et al. | 2022
- 481
-
An Analytical Solution for Saturable Absorption in Pharmacokinetics ModelsSorzano, C.O.S. / Moreno, M.A. Perez-de-la-Cruz / Vilas, J.L. et al. | 2022
- 487
-
Analytical Workflows to Unlock Predictive Power in Biotherapeutic DevelopabilityTrikeriotis, Markos / Akbulatov, Sergey / Esposito, Umberto / Anastasiou, Athanasios / Leszczyszyn, Oksana I. et al. | 2022
- 501
-
Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under UncertaintyAkalın, Ali Aykut / Dedekargınoğlu, Barış / Choi, Sae Rome / Han, Bumsoo / Ozcelikkale, Altug et al. | 2022
- 525
-
Random Heteropolymer Excipients Improve the Colloidal Stability of a Monoclonal Antibody for Subcutaneous AdministrationMessina, Kathryn M. M. / Woys, Ann Marie et al. | 2022
- 537
-
In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray PerformanceLi, Lillian / Wilkins, John V. / Esmaeili, Amir R. / Rahman, Nausheen / Golshahi, Laleh et al. | 2022
- 551
-
Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic PotentialAkif, Usmani Mohammed / Miyan, Javed / Rana, Rafquat / Goswami, Narayan Kumar / Bhadauria, Smrati / Chourasia, Manish Kumar et al. | 2023
- 567
-
Melt Crystallization of Celecoxib-Carbamazepine Cocrystals with the Synchronized Release of DrugsChen, An / Cai, Peishan / Luo, Minqian / Guo, Minshan / Cai, Ting et al. | 2022
- 579
-
Dissolution Profiles of Carbamazepine Cocrystals with Cis–Trans Isomeric CoformersOmori, Maaya / Yamamoto, Hibiki / Matsui, Fumiya / Sugano, Kiyohiko et al. | 2022
- 593
-
Advanced Solid Formulations For Vulvovaginal CandidiasisConte, Júlia / Parize, Alexandre Luis / Caon, Thiago et al. | 2022
- 611
-
Multiphysics Simulation in Drug Development and DeliveryZhan, Wenbo / Wang, Chi-Hwa et al. | 2022